Group 1 - The National Medical Products Administration (NMPA) has focused on key areas such as medical robots, high-end medical imaging, AI medical devices, and new biological materials to support the innovation of high-end medical devices [1] - In 2023, the NMPA has approved 52 innovative products, bringing the total to 367 approved innovative products to date [1] - The NMPA aims to encourage high-level global medical device products to debut in China, benefiting global public health with more high-quality products [1] Group 2 - Neusoft Medical Systems Co., Ltd. has received approval for its innovative X-ray computed tomography (CT) equipment, which includes various components such as a scanning frame, high-voltage generator, and photon counting detector [1] - The new product is designed for routine CT examinations and supports coronary CT angiography and spectral imaging [1] - The photon counting CT technology represents a significant breakthrough in CT imaging over the past decade, greatly improving traditional CT imaging methods and demonstrating notable clinical application value [1] Group 3 - Shanghai United Imaging Healthcare Co., Ltd. has also received approval for its photon counting CT [2] - The NMPA will continue to implement supportive measures to promote the market entry of more high-quality products [2]
国家药监局:今年以来已批准医疗器械创新产品52个